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Introduction
Preconception care means providing care before pregnancy is
established. Women and couples of reproductive age are generally
unaware of the effects that their own health conditions and health-
related behaviors may have on the fetus during pregnancy.
Although antenatal care is set in the maternal, newborn, and child
health (MNCH) continuum [1], it neglects the most critical time of
embryonic development, which often occurs before a woman even
knows she is pregnant [2]. The evidence increasingly points to
earlier care before pregnancy to improve women’s health, and
better pregnancy outcomes for the mother and newborn [3–5].
Preconception care may be defined as ‘‘any intervention
provided to women and couples of childbearing age, regardless
of pregnancy status or desire, before pregnancy, to improve health
outcomes for women, newborns and children’’ [3] or ‘‘a set of
interventions that aim to identify and modify biomedical,
behavioral, and social risks to a woman’s health or pregnancy
outcome through prevention and management’’ [4]. For instance,
education and awareness about nutritional anemia and congenital
malformations can increase receptiveness to and uptake of iron
and folic acid supplementation even before pregnancy. The
specific aim of preconception care is to improve pregnancy
outcomes for mothers and newborns, by optimizing health before
a possible pregnancy occurs. Under strict terms, the preconception
period may be defined as a minimum of three menstrual cycles
prior to the initiation of sexual intercourse, the intent of which is to
achieve a wanted and viable pregnancy. An exact ‘‘preconception
period’’ has not been standardized by the evidence base; however,
since many pregnancies are unplanned, and time to conception for
couples varies greatly. We propose that the preconception period
be defined as a minimum of one year prior to the initiation of any
unprotected sexual intercourse that could possibly result in a
pregnancy, reflecting the broader scope of preconception care that
extends to adolescents and all women and couples of reproductive
age.
A systematic review [3] established that there are currently three
levels of evidence within the area of preconception care. For some
preconception interventions, such as folic acid supplementation to
prevent neural tube defects, the evidence base is strong [6], yet
even in developed countries less than half of all women regularly
consume folic acid supplements around the time of conception [7].
In other areas, such as intervals between pregnancies, the data
shows significant risk in terms of excess maternal deaths, higher
rates of prematurity and stillbirths, with short inter-pregnancy
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intervals [8,9]; however, strategies to optimize birth spacing and
increase contraceptive uptake are lacking [10]. Finally in women’s
health, violence against girls and women; unsafe abortions; alcohol
and tobacco use; and harmful environmental exposures require
further substantiation of magnitude of pre-pregnancy risk, and
proof that prevention and management as part of preconception
care will have greater impact than prenatal care alone.
Preconception care has the potential to positively impact 208
million pregnancies worldwide each year [11]. Unfortunately,
many adolescent girls and women in low- and middle-income
countries (LMICs), which have the highest burden of maternal and
childhood mortality (map of global infant mortality [World Bank
2011] http://data.worldbank.org/indicator/SP.DYN.IMRT.IN/
countries?display =map and map of maternal mortality worldwide
[WHO2010] http://gamapserver.who.int/gho/interactive_charts/
mdg5_mm/atlas.html) [12,13], do not receive the benefits of these
interventions, either because they lack access to care or because it is
not routinely offered to them before pregnancy. Critical appraisal of
the literature review in light of the current global MNCH picture
suggests that the greatest benefit would be in these resource-poor
countries, and emphasizes the need for implementation strategies
and increasing coverage of existing cost-effective preconception
interventions.
Although present-day funding for global health is previously
unparalleled [14] and a substantial proportion of maternal and
child deaths in LMICs are preventable with existing interventions
[15–17], progress in reducing these deaths is far too slow. Perhaps
one contributing factor is the bias that remains in health care and
research investment—for example, worldwide 7.6 million children
died in 2010, equivalent to global deaths due to cancer and slightly
higher than deaths due to heart disease [18,19], yet funding favors
breakthrough research for cancer and heart disease, which have
high media interest, while implementation research and delivery
for maternal and child health is sidelined. The persisting high
mortality for mothers and children in LMICs [20,21], with its
repercussions on global MNCH and overall population health and
development, represents a continuing failure and challenge. We
assembled a group of maternal and child health professionals
whose specific goal was to identify and prioritize evidence-based,
equitable research investment opportunities for development and
increased delivery of effective preconception interventions in
LMIC, with the intent of reducing maternal, fetal, newborn, and
childhood mortality and severe morbidity.
Methods
The Child Health and Nutrition Research Initiative (CHNRI)
methodology for research priority-setting was proposed to inform
those who develop research policy and/or invest in health research
with the aim to impact population health and improve equity in
health care [22–24]. The process uses a systematic and transparent
approach involving an array of health professionals to enlist a wide
spectrum of research options relating to a certain health topic and
context. Research options are generated in a structured way, using
four basic domains: description (epidemiology), discovery (new
interventions), development (improving existing interventions),
and delivery (health policy and implementation). A priori criteria
relevant to the topic are used to score competing research
questions in all four domains and then order them in terms of
potential influence on health and equity (conceptual framework
shown in Figure 1; further details published in previous CHNRI
exercises) [25–27].
A notable difference from previous CHNRI exercises was the
application of the methodology in two iterations. Following an
initial consultation coordinated by the Harvard School of Public
Health, Aga Khan University, and the Bill & Melinda Gates
Foundation, a list of potential experts was drawn up by the
investigators in individual fields related to preconception care
(such as nutrition, mental health, and infectious diseases) as
identified by the initial review. The leads were approached to draw
Box 1. Preconception Risks and Interventions
Risks that could be reduced/mitigated Any known interventions?
BIOMEDICAL
Maternal pre-pregnancy overweight (body mass index) Weight loss programs for adults and post-partum women incorporating diet and/or
exercise
Poor nutrition and pre-pregnancy underweight Micronutrient supplementation
Chronic medical conditions (diabetes, hypertension, etc.) Counseling and optimizing glycemic control for pre-pregnancy diabetes
Infectious diseases especially sexually transmitted infections Immunization, screening and treatment
Genetic disorders, consanguinity Genetic counseling and screening
Mental health disorders
Advanced maternal age
SOCIAL
Unprotected sexual activity in adolescence resulting in teenage pregnancies Comprehensive adolescent pregnancy prevention programs
Inappropriate inter-pregnancy intervals Birth spacing and post-abortion contraceptive counseling
Lack of reproductive planning, resulting in unintended pregnancies, unsafe
abortions
Contraceptive provision and counseling
Coerced sex and Intimate partner violence School dating violence prevention programs
Female genital mutilation Women’s empowerment and community awareness
Substance use (tobacco, alcohol, illicit drugs, excessive caffeine)
ENVIRONMENTAL
Harmful environmental exposures
Bold type indicates strong evidence.
PLOS Medicine | www.plosmedicine.org 2 September 2013 | Volume 10 | Issue 9 | e1001508
up a list of key questions based on their assessment of research
gaps and identify additional subject experts to score the lists of
research questions using the original CHNRI criteria: answer-
ability in an ethical way; likelihood of effectiveness; deliverability,
affordability, and sustainability; maximum potential impact on
burden reduction; and impact on promoting greater equity in
health [22–24]. Forty-eight of 130 approached completed the
scoring (the scored lists may be accessed by contacting the
authors), and were geographically representative mainly of Asia,
North America, and South America. Many found criterion 4
‘‘maximum potential of disease burden reduction’’ difficult to
estimate, since preconception care to improve maternal and
neonatal outcomes is a relatively new avenue. There were also
discrepancies in the number and scope of research questions, as
well as number of scorers, for each field.
At a meeting of leading international MNCH experts, the
potential risk factors and interventions (Box 1) ascertained from
the AKU team’s systematic review of the literature on precon-
ception care [3 were presented, along with a synopsis of the first
iteration. These experts agreed to form a core working group
(CWG) to proceed with a second iteration of the CHNRI process
for preconception care in a more holistic manner.
The CHNRI methodology involves four stages (Table S1
provides more information about the modified process, limitations,
and validation) [27]:
(1) Defining Context and Criteria
An open group discussion was held during the CWG meeting to
define the context and criteria, with modifications being incorpo-
rated until all CWG members were satisfied. Over 90% of all
maternal and child deaths occur in LMICs, particularly South
Asia and sub-Saharan Africa [28]. Scaling up preconception care
directed at adolescents, women, and couples of reproductive age
in such high-burden, resource-poor regions could hasten the
decline in global maternal and childhood mortality and severe
morbidity through development and delivery of effective inter-
ventions. This became the context and target population for the
research priority-setting exercise, with a timeline for development
and delivery of interventions within 10 years. The CWG
emphasized the importance of local or regional MNCH priorities,
and underscored that investment in cross-cutting interventions
would have greater benefits in improving MNCH outcomes
[22,24].
The criteria were modified to reflect the context and subject of
preconception care, with criterion (iv) being amended to
‘‘maximum potential impact on reduction of maternal and
neonatal mortality and severe morbidity,’’ and addition of the
criterion ‘‘potential impact on long-term outcomes for women and
children.’’
(2) Expert Input-Listing and Scoring Competing
Research Options
Figure 1.Conceptual framework. Overview of the key steps in this adaptation of the CHNRI methodology.
doi:10.1371/journal.pmed.1001508.g001
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Experts were invited to participate on the basis of their record in
maternal and child health research relevant to preconception care.
There was an overlap of 11 experts who were involved in both
iterations. A serious attempt was made to be inclusive of experts
with varied areas of expertise and from different countries (Table
S2), with the addition of more experts from Europe and Africa in the
second iteration. Experts received a summary of findings with effect
sizes from the primary review, along with previously published
CHNRI exercises on childhood mortality and stillbirths to help
them understand the background literature and priority-setting
process. Experts used the CHNRI matrix (Table 1) to develop an
extensive list of research options (more expansive research ideas)
and research questions (narrower in focus) in preconception care.
In the second iteration, the CWG advised that the timelines
and criteria for the domains ‘‘description’’ and ‘‘discovery’’
would be inconsistent with those of ‘‘development’’ and
‘‘delivery,’’ and would therefore be ranked inaccurately. A
consensus was reached to focus on development and delivery to
enable preconception care services to reach women of repro-
ductive age, which would accelerate maternal and child
mortality and morbidity reduction in LMICs. Each expert in
the CWG presented further information in one area of
preconception care most relevant to their own experience and
suggested more research options. Short group discussions were
held at the end of each session to seek clarification, air dissenting
opinions, and outline the most important research options in
that area. The chairperson for each half-day session was tasked
with drawing out all opinions and promoting clarity, and
another member was assigned to document research options and
the group’s suggestions for emphasis or caveats therein. The lists
Box 2. Scoring Criteria Questions
CRITERION 1: Likelihood that research would lead to new knowledge (enabling a development/planning of an intervention) in an ethical way.
1. Would you say the research question is well framed and endpoints are well defined?
2. Based on: (i) the level of existing research capacity in proposed research; and (ii) the size of the gap from current level of knowledge to the proposed endpoints; would
you say that a study can be designed to answer the research question and to reach the proposed endpoints of the research?
3. Do you think that a study needed to answer the proposed research question would obtain ethical approval without major concerns?
CRITERION 2: Assessment of likelihood that the intervention resulting from proposed research would be effective.
1. Based on the best existing evidence and knowledge, would the intervention that would be developed/improved through proposed research be efficacious?
2. Based on the best existing evidence and knowledge, would the intervention that would be developed/improved through proposed research be effective?
3. If the answer to either of the previous two questions is positive, would you say that the evidence upon which these opinions are based is of high quality?
CRITERION 3: Assessment of deliverability, affordability, and sustainability of the intervention resulting from proposed research.
1. Taking into account the level of difficulty with intervention delivery from the perspective of the intervention itself (e.g., design, standardization, safety), the
infrastructure required (e.g., human resources, health facilities, communication, and transport infrastructure), and users of the intervention (e.g., need for change of
attitudes or beliefs, supervision, existing demand), would you say that the endpoints of the research would be deliverable within the context of interest?
2. Taking into account the resources available to implement the intervention, would you say that the endpoints of the research would be affordable within the context of
interest?
3. Taking into account government capacity and partnership requirements (e.g., governmental intersectoral coordination; partnership with civil society and external donor
agencies; favorable political climate to achieve high coverage), would you say that the endpoints of the research would be sustainable within the context of interest?
CRITERION 4: Assessment of maximum potential impact on reduction of maternal and neonatal mortality and severe morbidity.
1. Is this research likely to have substantial impact on maternal mortality and severe morbidity?
2. Is this research likely to have substantial impact on stillbirths reduction?
3. Is this research likely to have substantial impact on neonatal mortality and severe morbidity?
CRITERION 5: Assessment of potential impact on long-term outcomes for women and children.
1. Is this research likely to have substantial impact on long-term health outcomes for women?
2. Is this research likely to have substantial impact on long-term health outcomes for children?
3. Is this research likely to have substantial impact on fulfilling long-term socioeconomic potential of mother and child?
CRITERION 6: Assessment of the impact of proposed health research on equity.
1. Does the present distribution of the disease burden affect mainly the underprivileged in the population?
2. Would you say that either (i) mainly the underprivileged, or (ii) all segments of the society equally, would be the most likely to benefit from the results of the proposed
research after its implementation?
3. Would you say that the proposed research has the overall potential to improve equity in disease burden distribution in the long term (e.g., 10 years)?
Questions answered by technical experts to assign intermediate scores for each criterion to competing research options (possible answers: yes, 1; no, 0; informed but
undecided answer, 0.5; not sufficiently informed, left blank).
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of research questions from the first iteration were compressed to
highlight important gaps, yet still represent the range of research
possibilities in preconception care. The final list of research
questions was reviewed by the whole CWG at the end of the
meeting to ensure that they were framed correctly and
comprehensively to allow scoring. The CWG also attempted
to ensure that the phrasing of the research questions was not
rigid, so for example given the option ‘‘What approaches work
to increase the use of effective contraception…’’ research could
assess contraceptive counseling to educate and empower women
to plan their pregnancies in different settings, or women with
and without their husbands, and so forth. Each expert scored
the new list, assigning a score to each of 37 research questions in
the domains of development and delivery using the six modified
criteria (final criteria questions are shown in Box 2, the actual
scoring sheet used by experts is shown in Table S3). 24 of 30
scorers participated in the second iteration, which was accept-
able as it has been modeled that the CHNRI exercise reaches
saturation with 20–25 scorers.
The first iteration was conducted entirely via email from March
to June 2011. The research options for the second iteration were
developed during an expert meeting in July 2011, and the scoring
was completed via email by September 2011.
(3) Weighting criteria based on input from societal stakeholders
The scoring criteria may be perceived with varying importance
based on the perspective of different stakeholders. For example,
parents who experienced a stillbirth may rate mortality reduction
higher than a donor organization who may value answerability, or
a public health official most concerned with deliverability. For
previous CHNRI exercises, a range of stakeholders were polled to
weight the criteria [29]; however, the CWG decided not to assign
weights for this exercise. Rather, the final rankings are based on
the average merit of each research option across all scoring criteria
and expert perspectives.
(4) Computing Research Priority Scores (RPSs) and
Average Expert Agreement (AEA).
Overall RPS was calculated as the mean of scores for the six
criteria [23] according to the formula:
½(Criterion 1 score)z(Criterion 2 score)z(Criterion 3 score)z
(Criterion 4 score)z(Criterion 5 score)z(Criterion 6 score)=6
AEA was calculated for each research question as the average
proportion of scorers that gave the most common answer while
scoring that question:
1
18
|
X18
q~1
N (scorers who provided the most frequent response)
N (scorers)
(Where q is 1 of 18 criteria questions that experts used to evaluate
competing research options).
Results
Table 2 shows the top research questions (those with
RPS.80), of 381 in total (344 questions in the first iteration
and 37 questions in the second). Table S4 shows the final
scores and ranking of the research questions from the more
robust second iteration. The RPS indicates the perceived
likelihood that each research option will meet the chosen
priority-setting criteria. In the areas of development and
delivery of existing interventions, the highest-ranked research
option seeks to address the gap in coverage of nutritional
interventions, such as supplementation, through integration
with other programs. The specified context (expectation of
medium term impact in LMIC) allowed research to identify
obstacles to delivery of interventions, and research to optimize
the use of those interventions, to receive high scores. Priority
areas identified were adolescent health, chronic conditions,
infectious diseases and immunization, contraception, improving
Table 1. CHNRI matrix.
Research Instrument Research Avenue Research Option Research Question
Epidemiological research: DESCRIPTION Measuring the burden Experts were invited to use
categorization of research
avenues and instruments in
Preconception Care to
systematically propose a
number of ‘‘research
options’’
Experts were invited to propose a
number of specific ‘‘research questions.’’
After consolidation and removing of
duplicate ideas, 344 questions in the first
iteration and 37 in the second iteration
were retained for scoring
Understanding the risk factors
Evaluating the existing interventions
Health policy and systems research:
DELIVERY
Studying capacity to reduce exposure to proven
health risks
Studying capacity to deliver efficacious
interventions
Research to improve existing interventions:
DEVELOPMENT
Research to improve deliverability, affordability
and sustainability
Research for development of new
interventions: DISCOVERY
Basic research
Clinical research
Public health research
Framework from which listing of many research options (level of 3–5-year research program) and research questions (level of individual research papers) were
systematically proposed by technical experts.
doi:10.1371/journal.pmed.1001508.t001
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the supply chain for preconception commodities, and public
health approaches to reduce exposure to environmental
pollutants with adverse MNCH effects.
Three central issues were consistently emphasized, with experts
advocating for integration of preconception interventions with
other programs and systems; moving beyond the health care
Box 3. The Three Highest Scoring Research Questions within Each of the Six Priority-Setting Criteria
ANSWERABILITY
N What are the public health approaches to regulate and reduce exposures to environmental tobacco smoke? (96)
N What is the effect, cost, and feasibility of using cell phones and other information technologies to improve capacities of front-line workers to target and follow up
women of reproductive age for improved preconception health care? (95)
N What are effective, affordable, and feasible means to screen for diabetes affecting girls and women before conception? (95)
EFFECTIVENESS
N How can effective interventions to prevent adolescent pregnancy and repeat adolescent pregnancy be delivered at scale? (83)
N What are the public health approaches to regulate and reduce exposures to environmental tobacco smoke? (82)
N What are the most effective strategies to scale up the prevention/detection/treatment of malaria and helminthiasis to reduce anemia in women of reproductive age?
(82)
DELIVERABILITY
N What are the public health approaches to regulate and reduce exposures to environmental tobacco smoke? (90)
N How can cell phones and other information technologies be best utilized to improve care-seeking for preconception services and healthy behaviors, especially
amongst adolescents? (87)
N What is the effect, cost, and feasibility of using cell phones and other information technologies to improve capacities of front-line workers to target and follow up
women of reproductive age for improved preconception health care? (86)
IMPACT ON REDUCTION OF MATERNAL AND NEWBORN MORTALITY AND SEVERE MORBIDITY
N What effective, affordable strategies could be developed to provide effective STI/HIV identification and management, including early antiretroviral therapy, as part of
preconception care, and how could these be adapted to maximize uptake by adolescents? (85)
N What should constitute an essential package of preconception health interventions for all girls and women of reproductive age? (83)
N How can preconception nutrition interventions, such as diet diversity, micronutrient supplementation/fortification, and achieving optimal BMI, be integrated into
broader nutrition and/or health programs and delivered in a cost-effective manner? (82)
IMPACT ON LONG-TERM OUTCOMES FOR WOMEN AND CHILDREN
N How can preconception nutrition interventions, such as diet diversity, micronutrient supplementation/fortification, and achieving optimal BMI, be integrated into
broader nutrition and/or health programs and delivered in a cost-effective manner? (90)
N How can a package of promotive and preventive mental health interventions for women and girls be effectively and feasibly provided through community health
workers and/or groups, with linkages to the primary health care system for treatment? (89)
N What effective, affordable strategies could be developed to provide effective STI/HIV identification and management, including early antiretroviral therapy, as part of
preconception care, and how could these be adapted to maximize uptake by adolescents? (88)
EQUITY
N What effective strategies can be developed to modify individuals’ behavior to reduce their environmental exposures to smoke stoves? (95)
N What are the public health approaches to regulate and reduce environmental exposures to smoke stoves? (94)
N How can the quality of and access to comprehensive post-abortion care services (including contraceptive counseling, provided by different cadres of health care
workers, and adaptation to maximize uptake by adolescents) be improved? (89)
CHNRI criteria score: Range from 0 to 100.
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setting with task-shifting to community health workers (CHWs);
and maximizing uptake of preconception services by adolescents.
Addressing these fundamental issues enables interventions to be
delivered affordably and sustainably on a wider scale, yet they are
rarely considered by research funding agencies.
Although discovery research options were excluded (see ‘‘Input
from technical experts’’ above), questions suggested the need to
develop simple, cost-effective methods to screen for, diagnose, and
treat health conditions that have negative consequences particu-
larly for women of reproductive age. The research questions with
the lowest scores reflected interventions for which there is little
evidence of effect, such as strategies to promote women’s mental
health; reduce coerced sex and intimate partner violence; reduce
genetic disease risk in the community; and prevent or treat
substance use among women and couples of reproductive age.
Utilizing information technologies to improve demand for
preconception services was also ranked low because of uncertainty
about its potential to reduce mortality and severe morbidity.
Discrimination between levels of agreement among scorers on
the prioritization of research questions was achieved by calculating
AEA (Tables 2 and S4). AEA scores ranged from 60.5% to 84.2%,
indicating the proportion of scorers that gave the most common
score to an average criteria question for a specific research option.
In general, the questions with high AEA were also those that
achieved high RPS. Greater points of contention were research
options that would require individual behavior modification to
improve pre-pregnancy health, or a shift in cultural norms (e.g.,
economic incentives to increase demand for services, involving
men in preconception health, and addressing consanguinity).
The actual scores marked for all research questions by
individual experts and calculations for AEA are presented in
Table S5. The results exposed how research questions can be
prioritized in completely different ways, depending on the criterion
used. Box 3 shows the three highest scoring questions for each
of the six priority-setting criteria. The most answerable research
relates to developing public health approaches to reduce
environmental tobacco smoke exposure. This option was also
the highest ranked question for deliverability, and scored highly
on effectiveness and equity. Other answerable research possibilities
were development of diabetes screening tools, and evaluating
the feasibility of information technology as an aid for front-line
health workers in continuity of care. The ideas most likely to
be effective were scaling up interventions to prevent pregnancy
in adolescence and anemia in women of reproductive age.
The strongest opportunities to improve delivery were assessing
the use of cellphones and other information technologies to
increase demand for, and promote provision of, preconception
care services. The greatest impact on maternal and newborn
mortality and morbidity was assigned to developing strategies
to identify and manage sexually transmitted infections (STIs)/HIV
in the preconception population; deciding upon an essential
package of preconception interventions for all girls and women;
and studying how best to integrate nutrition interventions into
broader initiatives. It was agreed that two of these same research
questions would also have the greatest impact on long-term
outcomes for women and children. Engaging CHWs in primary
preventive and promotive mental health services was another
option thought to impact long-term outcomes. Research that
would maximally contribute to improving equity was evaluating
behavioral and public health strategies to reduce exposure to
smoke stoves. It was notably recommended that improved quality
and accessibility of post-abortion care services at all tiers of the
health system would also improve health equity for women of
reproductive age.
Discussion
This research priority-setting focused on development and
delivery of existing interventions during the preconception period
in LMICs. The latter has been recognized as a critically important
entry point to influence optimal health, nutrition, and birth
preparedness in LMICs [30]. The research questions that received
the highest scores therefore highlighted the need to develop
strategies to increase coverage of basic interventions such as
improving nutrition; reproductive planning for adolescents;
contraception; prevention, detection and treatment of chronic
conditions that affect maternal health; immunization, diagnosis,
and treatment of infectious diseases; and reducing harmful
environmental smoke exposures. The highest priorities also
advocated for a systems-based approach to increase preconception
care services in LMICs including integration with other programs;
task-shifting to CHWs; improving supply chains for preconception
care commodities; partnerships with media and information
technology; maximizing demand for and uptake of preconception
interventions, especially by adolescents.
The CHNRI methodology aims to ensure that those research
options with evidence of true potential impact in the chosen
context receive commensurate support from the global health
community. The simple, structured scoring method means that
those research options that meet most criteria and achieve high
expert consensus are ranked highly. Moreover, for each individual
research question it exposes strengths and weaknesses through
estimations collected from numerous technical experts from
various backgrounds. Although the CHNRI process attempts to
achieve fairness and greater accuracy in research priority-setting,
there are limitations to this method (Table S1). First, the list of
research questions developed is not exhaustive and therefore
cannot include all possible sound research ideas. Since our
primary review focused on health-related interventions in the
preconception period, social sector interventions were not
emphasized even though these indirectly promote health and
wellbeing. In this exercise, education or improving women’s
literacy was not suggested as a discrete research option although it
is an essential means to achieve preconception care and better
maternal health. However, this is a major component of other
research options that were elaborated, notably adolescent health
and pregnancy prevention programs, community-based platforms
that target maternal and newborn health in rural areas; and
utilizing media and information technology to reach adolescent
girls and women with preconception care information and
services. Second, the method of expert selection may be seen as
the initiator of the process tending to invite other like-minded
experts or experts known to them to participate. In this exercise,
the initiator invited only the first participants, and then asked them
to invite other MNCH experts representing their area of expertise
and other geographical regions. In the first iteration, three invited
experts were unable to participate in developing research options
and 82 were unable to score, with experts mostly commonly citing
time constraints as the reason for non-participation. Dissension
among experts was reflected in the AEA score, and rearranging
research options by this score did not make a significant difference
in their priority order since most options with high RPS (.80) also
had high AEA (.65). Third, in this application of the CHNRI
method, no stakeholder weighting was performed, hence the
results are reflective of MNCH experts but do not consider other
values that stakeholders might have.
This objective representation of research priorities may be used
to guide research policy that is likely to have an impact on the
health of women and couples of reproductive age, as well as their
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young children; and eventually make both research and health
care more equitable.
The United Nations Millennium Development Goals (MDGs)
aimed to reduce childhood mortality and improve maternal
health. While significant progress towards these targets has been
achieved, it is recognized that progress in reducing newborn
deaths is slow [12] and major challenges remain in reducing
maternal mortality [28]. Improving birth preparedness and the
health of the mother is a critical step in achieving these targets and
has received relatively less attention. The list of research ideas put
forth may not seem novel or innovative. Many are already
recognized gaps in MNCH. However since research in underlying
determinants of health, health policy, and systems, or applied
health are rarely appreciated by researchers and investors, this
exercise draws new attention to these long-standing concerns.
Addressing these issues in LMIC is crucial to build on our success
in improving MNCH as we move forward after 2015, the deadline
to meet the MDGs
New interventions and strategies, strengthened health systems,
quality services, and equity in coverage are needed to confront
infectious diseases, chronic conditions, unsafe abortions, and
undernutrition, prematurity, and stillbirths, which still threaten
maternal and child survival. It is imperative that preconception
care is seen as an earlier opportunity, not just for family planning
or to reduce maternal and neonatal mortality, but also to improve
long-term outcomes for adolescent girls, women, and children.
Adolescent health and reproductive health must increasingly be
considered as crucial stages in the continuum of care. Health
research investment and policy should be pursued in a more
balanced way, promoting increased access and delivery of an
essential package of preconception interventions. This exercise has
led to a concerted global effort led by the World Health
Organization to tackle the challenges of reaching girls and women
with preconception care services. Reaching a consensus on what
constitutes such a package of preconception interventions in
LMICs, and investing in implementation research to ensure
maximum coverage and uptake should be the next step. Within
LMICs, different regions and individual countries may need to
further prioritize their MNCH policies and research investment
according to their specific causes of maternal and newborn
mortality and morbidity and feasibility of scaling up certain
interventions.
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